(3S,4S)-3-FLUOROPIPERIDIN-4-OL HCL, 95.0%, 250mg

2,5-Dichlorothiophene-3-carboxylic acid, 95.0%, 5g

(3-Fluoro-phenyl)-methanesulfonyl chloride, 95.0%, 5g

2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid, 1g

5-Nitro-[1,1'-biphenyl]-2-carboxylic acid, 95.0%, 1g

Methyl-alpha-D-mannopyranoside, >=99%, for biochemistry, 250 g, plastic packaging.

5'-Bromo-2',3'-dihydrospiro[imidazolidine-4,1'-indene]-2,5-dione, 97%, 1g

3,5-dibromo-1-[(2E)-3-phenylprop-2-en-1-yl]-1H-1,2,4-triazole, 95.0%, 1g

2-[2-(2-Propyn-1-yloxy)ethoxy]acetic acid, 95%, 250mg

7-Bromo-3-chlorobenzo[d]isoxazole, 97%, 1g

Ethyl 2-{7-hydroxy-1H,2H,3H,4H-cyclopenta[b]indol-3-yl}acetate, 97%, 500mg

3,4-Dimethyl-1H-pyrazole, 95.0%, 50g

2-Formyl-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 5g